VIRTUS CONVERTIBLE & INCOME (NCZ)

US92838U1088

3.15  +0.02 (+0.64%)

After market: 3.1301 -0.02 (-0.63%)

Fundamental Rating

1

Overall NCZ gets a fundamental rating of 1 out of 10. We evaluated NCZ against 0 industry peers in the Unkown industry. NCZ may be in some trouble as it scores bad on both profitability and health. NCZ is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year NCZ was profitable.
In the past year NCZ had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NCZ reported negative net income in multiple years.
NCZ had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 1.14%
ROE 1.3%
ROIC 2.1%
ROA(3y)0.4%
ROA(5y)0.55%
ROE(3y)-0.8%
ROE(5y)-0.18%
ROIC(3y)2.42%
ROIC(5y)3.27%

1.3 Margins

In the last couple of years the Profit Margin of NCZ has declined.
NCZ's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of NCZ has declined.
Industry RankSector Rank
OM 60.26%
PM (TTM) 26.27%
GM 60.79%
OM growth 3Y-10.8%
OM growth 5Y-6.97%
PM growth 3Y-48.84%
PM growth 5Y-34.06%
GM growth 3Y-8.95%
GM growth 5Y-5.78%

2

2. Health

2.1 Basic Checks

The number of shares outstanding for NCZ remains at a similar level compared to 1 year ago.
NCZ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NCZ has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 1.98 indicates that NCZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of NCZ is 3.59, which is a good value as it means it would take NCZ, 3.59 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.12 indicates that NCZ is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.59
Altman-Z 1.98
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.81 indicates that NCZ may have some problems paying its short term obligations.
A Quick Ratio of 0.81 indicates that NCZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.57% over the past year.
Measured over the past years, NCZ shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -46.59% on average per year.
Looking at the last year, NCZ shows a decrease in Revenue. The Revenue has decreased by -6.24% in the last year.
The Revenue for NCZ have been decreasing by -18.86% on average. This is quite bad
EPS 1Y (TTM)101.57%
EPS 3Y-61.09%
EPS 5Y-46.59%
EPS Q2Q%-113.4%
Revenue 1Y (TTM)-6.24%
Revenue growth 3Y-24.06%
Revenue growth 5Y-18.86%
Sales Q2Q%-5.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 315.00, NCZ can be considered very expensive at the moment.
Compared to an average S&P500 Price/Earnings ratio of 27.73, NCZ is valued quite expensively.
Industry RankSector Rank
PE 315
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF 18.32
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 15.55%, NCZ is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.24, NCZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 15.55%

5.2 History

NCZ has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

814.20% of the earnings are spent on dividend by NCZ. This is not a sustainable payout ratio.
DP814.2%
EPS Next 2YN/A
EPS Next 3YN/A

VIRTUS CONVERTIBLE & INCOME

NYSE:NCZ (12/20/2024, 8:26:41 PM)

After market: 3.1301 -0.02 (-0.63%)

3.15

+0.02 (+0.64%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.45%
Inst Owner Change1.92%
Ins Owners0.06%
Ins Owner Change0%
Market Cap239.78M
Analysts0
Price TargetN/A
Short Float %0.32%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield 15.55%
Dividend Growth(5Y)N/A
DP814.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13 2025-03-13 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 315
Fwd PE N/A
P/S 12.77
P/FCF 18.32
P/OCF 18.32
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)0.01
EY0.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY5.46%
OCF(TTM)0.17
OCFY5.46%
SpS0.25
BVpS4.97
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.14%
ROE 1.3%
ROCE 2.83%
ROIC 2.1%
ROICexc 2.2%
ROICexgc 2.2%
OM 60.26%
PM (TTM) 26.27%
GM 60.79%
FCFM 69.74%
ROA(3y)0.4%
ROA(5y)0.55%
ROE(3y)-0.8%
ROE(5y)-0.18%
ROIC(3y)2.42%
ROIC(5y)3.27%
ROICexc(3y)2.53%
ROICexc(5y)3.44%
ROICexgc(3y)2.53%
ROICexgc(5y)3.44%
ROCE(3y)3.37%
ROCE(5y)4.33%
ROICexcg growth 3Y-23.98%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-23.98%
ROICexc growth 5Y-15.4%
OM growth 3Y-10.8%
OM growth 5Y-6.97%
PM growth 3Y-48.84%
PM growth 5Y-34.06%
GM growth 3Y-8.95%
GM growth 5Y-5.78%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.59
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 265.52%
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 1.98
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.57%
EPS 3Y-61.09%
EPS 5Y-46.59%
EPS Q2Q%-113.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.24%
Revenue growth 3Y-24.06%
Revenue growth 5Y-18.86%
Sales Q2Q%-5.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.75%
EBIT growth 3Y-32.26%
EBIT growth 5Y-24.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111.97%
OCF growth 3YN/A
OCF growth 5YN/A